|
|
Post by mannmade on Jan 10, 2018 13:44:03 GMT -5
www.yahoo.com/finance/m/3705dde4-f23d-3132-ad70-1d5c50606a38/ss_unitedhealth-taps-into.htmlJAN 10, 2018 @ 08:08 AM 658 The Little Black Book of Billionaire Secrets UnitedHealth Taps Into Emerging Mobile Diabetes Management UnitedHealth Group Inc. signage stands in front of company headquarters in Minnetonka, Minnesota, U.S., on Wednesday, March 9, 2016. Photographer: Mike Bradley/Bloomberg UnitedHealth Group Wednesday said it has partnered with DexCom to launch a glucose monitoring program that uses a wearable device to help older Americans continuously manage their Type 2 diabetes via mobile technology. Initially, the pilot program will involve giving an undisclosed number of enrollees in UnitedHealthcare’s Medicare Advantage plans a device that includes an activity tracker. Health plan enrollees can use the “Dexcom Mobile Continuous Glucose Monitoring System” to track their blood glucose levels around the clock. “Continuous glucose monitoring can be a game changer for people enrolled in our Medicare Advantage plans, as the data can be translated into personalized information that can be acted upon in real time,” Brian Thompson, CEO of UnitedHealthcare’s Medicare and retirement unit said. The business of mobile monitoring technology to manage chronic conditions is becoming more competitive with big names in technology and health insurance developing products, devices and attracting investments. Already in the market with a mobile device and diabetes management program is fast-growing startup Livongo Health. Last year, Livongo attracted more than $50 million in new funding to “accelerate growth in diabetes management , expand to other chronic conditions, and move to international markets,” the company said at the time. In addition, Blue Cross and Blue Shield plans including Anthem have partnered with Alphabet-backed Onduo to monitor glucose levels of patients with diabetes using a wearable device the insurers hope will improve health outcomes. A pilot is beginning this year, the Blue Cross Blue Shield Association has said. The Forbes eBook On Obamacare Inside Obamacare: The Fix For America’s Ailing Health Care System explores the ways the Affordable Care Act will impact your health care. Health plans and technology companies in the space see the costs of diabetes as a significant driver of premium increases with more than 30 million Americans, or 9% of the U.S. population, suffering from diabetes, according to the American Diabetes Association. Another estimated 30 million Americans have diabetes but have yet to have it diagnosed, ADA statistics show. For now, UnitedHealth says its effort with Dexcom is a pilot project for 2018 and decisions have yet to be made on giving the device to all Medicare Advantage enrollees. UnitedHealthcare has more than 4.3 million seniors enrolled in its Medicare Advantage plans .
|
|
|
|
Post by dreamboatcruise on Jan 10, 2018 14:42:49 GMT -5
www.yahoo.com/finance/m/3705dde4-f23d-3132-ad70-1d5c50606a38/ss_unitedhealth-taps-into.htmlJAN 10, 2018 @ 08:08 AM 658 The Little Black Book of Billionaire Secrets UnitedHealth Taps Into Emerging Mobile Diabetes Management UnitedHealth Group Inc. signage stands in front of company headquarters in Minnetonka, Minnesota, U.S., on Wednesday, March 9, 2016. Photographer: Mike Bradley/Bloomberg UnitedHealth Group Wednesday said it has partnered with DexCom to launch a glucose monitoring program that uses a wearable device to help older Americans continuously manage their Type 2 diabetes via mobile technology. Initially, the pilot program will involve giving an undisclosed number of enrollees in UnitedHealthcare’s Medicare Advantage plans a device that includes an activity tracker. Health plan enrollees can use the “Dexcom Mobile Continuous Glucose Monitoring System” to track their blood glucose levels around the clock. “Continuous glucose monitoring can be a game changer for people enrolled in our Medicare Advantage plans, as the data can be translated into personalized information that can be acted upon in real time,” Brian Thompson, CEO of UnitedHealthcare’s Medicare and retirement unit said. The business of mobile monitoring technology to manage chronic conditions is becoming more competitive with big names in technology and health insurance developing products, devices and attracting investments. Already in the market with a mobile device and diabetes management program is fast-growing startup Livongo Health. Last year, Livongo attracted more than $50 million in new funding to “accelerate growth in diabetes management , expand to other chronic conditions, and move to international markets,” the company said at the time. In addition, Blue Cross and Blue Shield plans including Anthem have partnered with Alphabet-backed Onduo to monitor glucose levels of patients with diabetes using a wearable device the insurers hope will improve health outcomes. A pilot is beginning this year, the Blue Cross Blue Shield Association has said. The Forbes eBook On Obamacare Inside Obamacare: The Fix For America’s Ailing Health Care System explores the ways the Affordable Care Act will impact your health care. Health plans and technology companies in the space see the costs of diabetes as a significant driver of premium increases with more than 30 million Americans, or 9% of the U.S. population, suffering from diabetes, according to the American Diabetes Association. Another estimated 30 million Americans have diabetes but have yet to have it diagnosed, ADA statistics show. For now, UnitedHealth says its effort with Dexcom is a pilot project for 2018 and decisions have yet to be made on giving the device to all Medicare Advantage enrollees. UnitedHealthcare has more than 4.3 million seniors enrolled in its Medicare Advantage plans . Getting CGMs into the elderly diabetic population cannot happen too soon. Diabetes is linked to dementia and likely in a spiral sort of way... uncontrolled BG causes progression of dementia and dementia contributes to an inability for patients to properly deal with their diabetes leading to deterioration of BG control. Having the ability for healthcare providers and/or family to review CGM data can provide crucial insight and warning. As I've mentioned before, I lost a family member to uncontrolled diabetes who was in a skilled nursing setting, but where the care was obviously nowhere near what it should have been. A CGM could have literally been a lifesaver. Hopefully anyone with a loved one in such a situation will push to get a CGM. |
|
|
|
Post by sayhey24 on Jan 10, 2018 15:12:50 GMT -5
Monitoring is great but then you need to do something www.ispot.tv/ad/wfAa/lifelock-bankTime in T2s is critical. They need afrezza as soon as they are found to be Prediabetic for the best chance of reversal. Today we send them home and tell them to lose a few pound and take a walk. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 10, 2018 16:16:36 GMT -5
That Dexcom sensor can send the info to a smartphone and from there, automatically send the data to Verily. Every 5 minutes, patient Doe sends their glucose reading. Smartphone has accelerometer to track activity. Smartphone can be loaded with apps the help coach the patient. Healthcoach and txt patient to set up time to speak and patient can talk to health coach , dietician, CNP with a diabetes specialty about anything that impacts patient Doe's diabetes. Follow up as well. Wanna see a hospital that has no patient beds? www.mercyvirtual.net |
|
|
|
Post by sayhey24 on Jan 10, 2018 16:26:42 GMT -5
That Dexcom sensor can send the info to a smartphone and from there, automatically send the data to Verily. Every 5 minutes, patient Doe sends their glucose reading. Smartphone has accelerometer to track activity. Smartphone can be loaded with apps the help coach the patient. Healthcoach and txt patient to set up time to speak and patient can talk to health coach , dietician, CNP with a diabetes specialty about anything that impacts patient Doe's diabetes. Follow up as well. Wanna see a hospital that has no patient beds? www.mercyvirtual.netGreat - we monitor and then we talk and then what happens after the talk? They need to stop the spike. The metformin is not going to stop the after meal spike, nor is the januvia or whatever else they may be giving these people. A highly restrictive diet will help but the key word is highly restrictive like Dr. Bernstein's. |
|
|
|
Post by dreamboatcruise on Jan 10, 2018 16:42:07 GMT -5
That Dexcom sensor can send the info to a smartphone and from there, automatically send the data to Verily. Every 5 minutes, patient Doe sends their glucose reading. Smartphone has accelerometer to track activity. Smartphone can be loaded with apps the help coach the patient. Healthcoach and txt patient to set up time to speak and patient can talk to health coach , dietician, CNP with a diabetes specialty about anything that impacts patient Doe's diabetes. Follow up as well. Wanna see a hospital that has no patient beds? www.mercyvirtual.netMy understanding of HIPAA is that the data could not be sent to third party even with identity stripped unless consent is given. There are real concerns about the ability to identify individuals even when their nominal identity (name or social security number) has been stripped. Onduo, which is a spin off of Verily, is one of those companies that provides app and remote coaching. When one consents to use Onduo they are likely consenting to Onduo using the data for analysis and coaching purposes. Though still, that doesn't give Onduo right to share/sell data... likely not even sharing with Sanofi or Verily (its owners). |
|
|
|
Post by joeypotsandpans on Jan 10, 2018 17:20:34 GMT -5
That Dexcom sensor can send the info to a smartphone and from there, automatically send the data to Verily. Every 5 minutes, patient Doe sends their glucose reading. Smartphone has accelerometer to track activity. Smartphone can be loaded with apps the help coach the patient. Healthcoach and txt patient to set up time to speak and patient can talk to health coach , dietician, CNP with a diabetes specialty about anything that impacts patient Doe's diabetes. Follow up as well. Wanna see a hospital that has no patient beds? www.mercyvirtual.netMy understanding of HIPAA is that the data could not be sent to third party even with identity stripped unless consent is given. There are real concerns about the ability to identify individuals even when their nominal identity (name or social security number) has been stripped. Onduo, which is a spin off of Verily, is one of those companies that provides app and remote coaching. When one consents to use Onduo they are likely consenting to Onduo using the data for analysis and coaching purposes. Though still, that doesn't give Onduo right to share/sell data... likely not even sharing with Sanofi or Verily (its owners). I consider that a relative non issue, what's the difference between that and the standard form the patient signs when they check in for the first time giving consent for the physician to share lab results etc., with any referring physicians, etc...I would venture to say that most patients sign those forms without even reading past the first paragraph. |
|
|
|
Post by dreamboatcruise on Jan 10, 2018 17:51:01 GMT -5
My understanding of HIPAA is that the data could not be sent to third party even with identity stripped unless consent is given. There are real concerns about the ability to identify individuals even when their nominal identity (name or social security number) has been stripped. Onduo, which is a spin off of Verily, is one of those companies that provides app and remote coaching. When one consents to use Onduo they are likely consenting to Onduo using the data for analysis and coaching purposes. Though still, that doesn't give Onduo right to share/sell data... likely not even sharing with Sanofi or Verily (its owners). I consider that a relative non issue, what's the difference between that and the standard form the patient signs when they check in for the first time giving consent for the physician to share lab results etc., with any referring physicians, etc...I would venture to say that most patients sign those forms without even reading past the first paragraph. The suggestion had been made that there is an agreement whereby Google/verily will monetize personal health metric readings collected from Dexcom meters and pay Dexcom up $1B or more for that data. That is very different than signing a form that says info can be sent to another personal care physician... and current practice is that you sign consent on the other end as well, giving the specialist approval to request your info (if it's not a referral from the first). If a doctor were to slip in language in those forms, that no one reads, stating that they could sell your medical record data, would you not mind? do you think that would fly as legal under HIPAA? I would think that if a doctor had health practice legal representation, the attorney would be jumping up and down screaming if that was proposed. I would also think that an attorney would scream at Dexcom if they suggested slipping in a clause into the "no one reads" fine print that they have the right to sell all your CGM data. I think some people assume that the biggest barrier to utilizing the wealth of electronic health data that already exists is a technology problem, whereas it mostly is a patient privacy issue. I did some consulting for a company a number of years ago that was developing a way of creating anonymized medical databases that could be queried and yet prevent (or greatly complicate) using the data that is there to figure out patient identity, so I'm a little bit aware of HIPAA privacy issues despite not having actually worked in healthcare field. |
|
|
|
Post by sayhey24 on Jan 11, 2018 6:30:15 GMT -5
Why does Verily need to pay Dexcom? Dexcom becomes a commodity device, along with Libre and the rest.
The meters would send directly to the Verily "Cloud Service" just like you can do with Nighscout today. Remember Google brought $250M of in-kind technical capability Verily deal. Some "Cloud" stuff and some predictive algorithms (which are IMO pretty much useless with afrezza).
You sign up for the Verily service. Its your decision if you want your doctor to be able to access your data but Verily wants to be the primary diabetes doctor and coach through their Teledoc service. Verily cuts the deals with insurance companies and as a PWD I have the option to allow reporting to the insurance company for the "pay for performance" discounts. Just like the dongle Liberty Mutual and Progressive give out if you want a discount on your car insurance.
Pay for performance is coming very fast now that we have the CGMs and Cloud in place. Diabetes is a huge health cost and if the insurance companies can keep you healthy to 65 then they can off load you to Medicare and at that point they don't care what you die from. However if they can stop the heart attack at 60 and all the health costs prior its a HUGE win for them.
However, monitoring is not good enough. They need to address the root cause which is the after meal BG spike.
|
|
|
|
Post by careful2invest on Jan 11, 2018 11:48:46 GMT -5
Sayhay wrote..."However, monitoring is not good enough. They need to address the root cause which is the after meal BG spike."
Exactly!
And Afrezza is best at achieving this goal, right?
Which makes it so very puzzleing why AFREZZA is not front page news everywhere that CGM monitoring systems are mentioned.
And here we sit at around 500 scripts/week.
It just does not make sense!
I would love to think that our new CEO has agreements/contracts pending that marry the two. (CGM &Afrezza)
and soon Afrezza (and Alfred Mann) get the credit and market acceptance that is so long overdue!
We should know very soon!
GLTA!
|
|
|
|
Post by agedhippie on Jan 13, 2018 10:21:31 GMT -5
|
|
|
|
Post by dreamboatcruise on Jan 13, 2018 12:02:26 GMT -5
Why does Verily need to pay Dexcom? Dexcom becomes a commodity device, along with Libre and the rest. The meters would send directly to the Verily "Cloud Service" just like you can do with Nighscout today. Remember Google brought $250M of in-kind technical capability Verily deal. Some "Cloud" stuff and some predictive algorithms (which are IMO pretty much useless with afrezza). You sign up for the Verily service. Its your decision if you want your doctor to be able to access your data but Verily wants to be the primary diabetes doctor and coach through their Teledoc service. Verily cuts the deals with insurance companies and as a PWD I have the option to allow reporting to the insurance company for the "pay for performance" discounts. Just like the dongle Liberty Mutual and Progressive give out if you want a discount on your car insurance.Pay for performance is coming very fast now that we have the CGMs and Cloud in place. Diabetes is a huge health cost and if the insurance companies can keep you healthy to 65 then they can off load you to Medicare and at that point they don't care what you die from. However if they can stop the heart attack at 60 and all the health costs prior its a HUGE win for them. However, monitoring is not good enough. They need to address the root cause which is the after meal BG spike. For clarification... do you have a source of information that they are doing these things including pay for performance discounts, or is that what you imagine/hope they will do? It isn't always clear in your posts what you are trying to convey. I've discussed these cost dynamics with a friend that is a finance exec with a healthcare system. Sadly, as I've stated, they don't take the long term view of things. They aren't asking what will prevent the heart attack at 60 when someone is 50. The bonuses for management are based on this years profits. It would be nice to think that everyone in our healthcare system was concerned about providing the best healthcare possible, but that all too often takes a back seat to short term profitability. |
|
|
|
Post by mango on Jan 13, 2018 13:29:01 GMT -5
I consider that a relative non issue, what's the difference between that and the standard form the patient signs when they check in for the first time giving consent for the physician to share lab results etc., with any referring physicians, etc...I would venture to say that most patients sign those forms without even reading past the first paragraph. The suggestion had been made that there is an agreement whereby Google/verily will monetize personal health metric readings collected from Dexcom meters and pay Dexcom up $1B or more for that data. That is very different than signing a form that says info can be sent to another personal care physician... and current practice is that you sign consent on the other end as well, giving the specialist approval to request your info (if it's not a referral from the first). If a doctor were to slip in language in those forms, that no one reads, stating that they could sell your medical record data, would you not mind? do you think that would fly as legal under HIPAA? I would think that if a doctor had health practice legal representation, the attorney would be jumping up and down screaming if that was proposed. I would also think that an attorney would scream at Dexcom if they suggested slipping in a clause into the "no one reads" fine print that they have the right to sell all your CGM data. I think some people assume that the biggest barrier to utilizing the wealth of electronic health data that already exists is a technology problem, whereas it mostly is a patient privacy issue. I did some consulting for a company a number of years ago that was developing a way of creating anonymized medical databases that could be queried and yet prevent (or greatly complicate) using the data that is there to figure out patient identity, so I'm a little bit aware of HIPAA privacy issues despite not having actually worked in healthcare field. Dexcom is wanting to make it to where the data from their devices can be automatically uploaded into the EHR. I'm not really sure what ya'll are talking about but personal health information cannot be sold. That is illegal. |
|
|
|
Post by agedhippie on Jan 13, 2018 15:30:08 GMT -5
The suggestion had been made that there is an agreement whereby Google/verily will monetize personal health metric readings collected from Dexcom meters and pay Dexcom up $1B or more for that data. That is very different than signing a form that says info can be sent to another personal care physician... and current practice is that you sign consent on the other end as well, giving the specialist approval to request your info (if it's not a referral from the first). If a doctor were to slip in language in those forms, that no one reads, stating that they could sell your medical record data, would you not mind? do you think that would fly as legal under HIPAA? I would think that if a doctor had health practice legal representation, the attorney would be jumping up and down screaming if that was proposed. I would also think that an attorney would scream at Dexcom if they suggested slipping in a clause into the "no one reads" fine print that they have the right to sell all your CGM data. I think some people assume that the biggest barrier to utilizing the wealth of electronic health data that already exists is a technology problem, whereas it mostly is a patient privacy issue. I did some consulting for a company a number of years ago that was developing a way of creating anonymized medical databases that could be queried and yet prevent (or greatly complicate) using the data that is there to figure out patient identity, so I'm a little bit aware of HIPAA privacy issues despite not having actually worked in healthcare field. Dexcom is wanting to make it to where the data from their devices can be automatically uploaded into the EHR. I'm not really sure what ya'll are talking about but personal health information cannot be sold. That is illegal. Dexcom will already automatically upload data into your EHR if you want it to and the provider (the medical provider is usually the problem) is capable of taking the data. |
|
|
|
Post by mango on Jan 13, 2018 16:09:54 GMT -5
Dexcom is wanting to make it to where the data from their devices can be automatically uploaded into the EHR. I'm not really sure what ya'll are talking about but personal health information cannot be sold. That is illegal. Dexcom will already automatically upload data into your EHR if you want it to and the provider (the medical provider is usually the problem) is capable of taking the data. They announced at the J.P. Morgan Healthcare Conference something about it, and the way the CEO said it was as if it was something new. The physician won't have to do anything to retreive it, the CGM data will automatically be sent into the person's EHR. |
|
